31. Haemorrhage and amyloidosis. (13th December 2012) Authors: Veneri, Dino; Pizzolo, Giovanni; Bonalumi, Angela; Franchini, Massimo Journal: British journal of haematology Issue: Volume 160:Number 6(2013:Mar.) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?. Issue 3 (4th March 2021) Authors: Franchini, Massimo; Schiavulli, Michele; Liumbruno, Giancarlo Maria Journal: Expert review of hematology Issue: Volume 14:Issue 3(2021) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. High‐titer convalescent plasma therapy for coronavirus disease 2019 and mortality. Issue 6 (26th May 2021) Authors: Cruciani, Mario; Bongiovanni, Giulio; Franchini, Massimo Journal: Transfusion Issue: Volume 61:Issue 6(2021) Page Start: 1988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Inhibitor eradication with rituximab in haemophilia: where do we stand?. (15th March 2014) Authors: Franchini, Massimo; Mannucci, Pier Mannuccio Journal: British journal of haematology Issue: Volume 165:Number 5(2014:Jun.) Page Start: 600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Inside out the thrombus: Defining the role of von Willebrand factor. Issue 144 (August 2016) Authors: Franchini, Massimo; Lippi, Giuseppe Journal: Thrombosis research Issue: Issue 144(2016) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Inside out the thrombus: Defining the role of von Willebrand factor. Issue 144 (August 2016) Authors: Franchini, Massimo; Lippi, Giuseppe Journal: Thrombosis research Issue: Issue 144(2016) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Investigational drugs to treat hemophilia. (3rd March 2020) Authors: Franchini, Massimo; Marano, Giuseppe; Pati, Ilaria; Veropalumbo, Eva; Vaglio, Stefania; Pupella, Simonetta; Masiello, Francesca; Cruciani, Mario; Mengoli, Carlo; Liumbruno, Giancarlo Maria Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 3(2020) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Investigational drugs to treat hemophilia. (3rd March 2020) Authors: Franchini, Massimo; Marano, Giuseppe; Pati, Ilaria; Veropalumbo, Eva; Vaglio, Stefania; Pupella, Simonetta; Masiello, Francesca; Cruciani, Mario; Mengoli, Carlo; Liumbruno, Giancarlo Maria Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 3(2020) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?. (3rd December 2021) Authors: Focosi, Daniele; Franchini, Massimo; Pirofski, Liise‐anne; Maggi, Fabrizio; Casadevall, Arturo Journal: Reviews in medical virology Issue: Volume 32:Number 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Is there a standard-of-care for transfusion therapy in thalassemia?. Issue 6 (November 2017) Authors: Franchini, Massimo; Forni, Gian L.; Liumbruno, Giancarlo M. Journal: Current opinion in hematology Issue: Volume 24:Issue 6(2017:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗